BSE · GVBL

GENOMIC VALLEY BIOTECH LIMITED

Sector: Healthcare · ISIN: INE574D01010

Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.

Market cap rank

#4,590

of 5,084 stocks

→ 01W

Peak #4,590 · 21 Sep 2026

GENOMIC VALLEY BIOTECH LIMITED, a microcap Healthcare business, carries a steep earnings multiple that prices in strong future growth, is growing revenue rapidly, and has a subdued return on equity. Ownership as of Jun 2026.

Market Cap

9.28 Cr

P/E Ratio

303.90

P/B Ratio

2.36

ROE

0.77%

ROCE

1.02%

Dividend Yield

—

52W High

—

52W Low

—

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q1 2025-26
Revenue	3.80 L	3.75 L	5.00 L	9.00 L
Net Profit	1.46 L	-Rs 81,745	1.05 L	2.47 L
EPS	0.05	-0.03	0.03	0.08
Operating Profit	1.46 L	Rs 15,625	1.05 L	2.47 L

Figures in Cr (crore) unless noted. Source: official company financial disclosures.

Shareholding pattern

Promoter

46.06%

Public

53.94%

PUBLIC BREAKDOWN

Individuals

50.91%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

Recent corporate actions

Ex-Date	Type	Details
06 Feb 2019	Other	E.G.M.

Need this data in your app?

Full price history, technical indicators, and every field above via one REST API call.

View API docs